Abstract
We report a case of significant pulmonary hemorrhage developing shortly after commencing ticagrelor and aspirin therapy and requiring coronary artery bypass grafting to safely cease the antiplatelet therapy. Lung biopsy fi ndings were consistent with druginduced lung injury. Clinicians should be aware of this significant adverse event with this drug class. © 2014 American College of Chest Physicians.
Original language | English |
---|---|
Pages (from-to) | 639-641 |
Journal | Chest |
Volume | 145 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2014 |